According to filings with the U.S. Securities and Exchange Commission, Etiometry is raising $10,000,000.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Shane Cooke played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Etiometry
Etiometry is a digital health company with leading-edge software platforms for clinical decision-support in critical care. By consolidating data from many ICU devices, the Etiometry Platform helps clinicians better understand the trajectory of their patients by viewing comprehensive clinical information on a single screen. It fosters more objective communication among care teams and provides a common platform to analyze the best course of treatment for ICU patients. The Etiometry Platform is an end-to-end solution for collection, analysis, visualization, and archiving of clinical data. It is designed to enhance the use of available data to anticipate and manage the dynamic condition of patients requiring intensive care. The Platform consists of three integrated software components: T3 Data Aggregation and Visualization Software, Risks Analytics Engine, and the Quality Improvement System. Together these systems provide critical information for immediate patient care and trajectory of patient condition, generate risk estimation of compromised patient conditions, and archives data for research and quality improvement initiatives. The Etiometry Platform features a web-based architecture that is hosted in a hospital s data center and protected by the hospital s firewall, and it encompasses all of the Etiometry products under a unified architecture.

To learn more about Etiometry, visit http://www.etiometry.com/

Contact:
Shane Cooke, President and Chief Executive Officer
857-366-9333
https://www.linkedin.com/in/shane-cooke-3759753/

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.